Inizio Ignite

Multisorb Commences Manufacturing Operations in Hyderabad, India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Nitrosamine Risk Mitigation in Global Pharma Manufacturing

Nitrosamine risk mitigation in global pharma manufacturing requires proactive control of chemical pathways, excipients, and operational practices to prevent trace-level carcinogenic impurities. Advanced analytics, rigorous risk assessments, and strengthened GMP frameworks are now essential to ensure long-term product safety and regulatory compliance.

Mycotoxins Risk Monitoring in Global Pharma Supply Chains

As global pharmaceutical supply chains expand across diverse climates and sourcing regions, the risk of resilient fungal toxins entering drug products has intensified. Effective mycotoxins risk monitoring now demands proactive, data-driven oversight, advanced analytics, and integrated quality frameworks to protect patient safety at every stage of production.
- Advertisement -

Multisorb, the leading provider of oxygen and moisture management technologies, announced the inauguration of a new manufacturing facility in Hyderabad, India.

This facility will be capable of producing Multisorb’s MiniPax®, StripPax®, IntelliSorb® and StabilOx® active packaging components, all industry-leading solutions for providing chemical and physical stability in pharmaceuticals and medical devices.

This new facility has completed validation and will begin production and delivery of Multisorb’s sorbent products in the coming weeks. The location was strategically selected to serve India’s growing Pharmaceutical sector, allowing Multisorb to better serve its India-based customers by dramatically shortening order-fulfillment lead time.


“Ultimately this leads to a more nimble relationship between Multisorb and its India-based customers. Our new location also provides the additional capacity necessary to accommodate growth at the pace of our customers’ needs,” said Eric Armenat, President and Chief Executive Officer, Multisorb.

Multisorb’s Hyderabad facility is ISO 9001:2015 certified and is held to the same high-quality standards and procedures deployed in the company’s U.S. production facilities.

“Companies in India have played a significant role in global pharmaceutical manufacturing for many years,” advised Laxmikant Khaitan, General Manager, Multisorb. “We are very excited for the opportunity to build stronger relationships with the local community and customer base.”

Multisorb is a business of Filtration Group, the global leader in advanced filtration solutions across life science and industrial applications. With more than 100 locations globally and nearly two dozen locations in Asia-Pacific, Filtration Group is poised for additional growth in these key markets—both by bringing manufacturing operations and innovation centers closer to its customers and by leveraging new opportunities as these markets expand.


“We have invested in this world class facility to be closer to our customers and to continue to exceed their expectations in quality of product and service” said Jon Peacock, President of Filtration Group’s Life Sciences division.

For more information on Multisorb and Filtration Group visit www.multisorb.comand www.filtrationgroup.com

About Multisorb
Multisorb, a Filtration Group company, has been innovating sorbent technology that delivers reliable protection against moisture, oxygen and volatiles/odors for more than 50 years. Multisorb has become the industry’s most distinguished oxygen absorber and desiccant supplier, developing superior sorbent solutions for healthcare, food, industrial and electronics applications. The ongoing commitment to advancing technology based on our customers’ changing needs has made Multsorb the World Leader in Active Packaging Technology®.

About Filtration Group
Filtration Group, an affiliate of Madison Industries, is making the world safer, healthier and more productive by creating innovative solutions that deliver outstanding customer value.  With a passionate team, global footprint and leading technology, Filtration Group is driving innovation and developing unparalleled filtration solutions.  Filtration Group serves a highly diverse set of customers with offerings that span life science, industrial technologies, fluid and indoor air quality applications.  One of the fastest growing companies in the industry, Filtration Group serves its customers from 107 facilities in over 28 countries.  Please visit Filtration Group and Madison Industries at: www.filtrationgroup.comand www.madison.net

Latest stories

Related stories

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Nitrosamine Risk Mitigation in Global Pharma Manufacturing

Nitrosamine risk mitigation in global pharma manufacturing requires proactive control of chemical pathways, excipients, and operational practices to prevent trace-level carcinogenic impurities. Advanced analytics, rigorous risk assessments, and strengthened GMP frameworks are now essential to ensure long-term product safety and regulatory compliance.

Mycotoxins Risk Monitoring in Global Pharma Supply Chains

As global pharmaceutical supply chains expand across diverse climates and sourcing regions, the risk of resilient fungal toxins entering drug products has intensified. Effective mycotoxins risk monitoring now demands proactive, data-driven oversight, advanced analytics, and integrated quality frameworks to protect patient safety at every stage of production.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »